Clinical phosphoproteomic profiling for personalized targeted medicine using reverse phase protein microarray
- 17 June 2006
- journal article
- perspectives
- Published by Springer Nature in Targeted Oncology
- Vol. 1 (3) , 151
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Global landscape of protein complexes in the yeast Saccharomyces cerevisiaeNature, 2006
- Proteome survey reveals modularity of the yeast cell machineryNature, 2006
- A comprehensive pathway map of epidermal growth factor receptor signalingMolecular Systems Biology, 2005
- Genomic and proteomic technologies for individualisation and improvement of cancer treatmentEuropean Journal of Cancer, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapyLeukemia, 2003
- From genomics to proteomicsNature, 2003
- The HUPO Proteomics Standards Initiative meeting: towards common standards for exchanging proteomics dataComparative and Functional Genomics, 2003
- Computational analysis of microarray dataNature Reviews Genetics, 2001
- The Hallmarks of CancerCell, 2000